Target Group Inc. (OTCQB: CBDY) today announced an exclusive licensing, distribution and central processing agreement for Canada and Europe with Massachusetts-based CannaKorp Inc. (“CannaKorp”)...
Target Group Inc. (“Target” or the “Company”) (OTC: CBDY) announced today its Common shares have been upgraded to a listing on the OTCQB...
Effective August 2, 2018, Target Group Inc. (CBDY) completed the acquisition of all of the issued and outstanding common stock of Visava Inc. (“Visava”)....
Visava Inc., 100% owner of Canary RX Inc. has been acquired by Target Group Inc. (CBDY) Effective June 27, 2018, Target Group Inc. ( CBDY )...
Late stage ACMPR Applicant, Canary, receives ‘Letter of Readiness’ from Health Canada Canary Rx Inc. (“Canary”) is pleased to announce that it has...
Canary’s Intuitive, Systematic, Record Keeping Platform One of the key requirements of the Access to Cannabis for Medical Purposes Regulations (ACMPR) is that...
Health Canada Notifies Canary of Active Review Status Canary Rx Inc. (“Canary”) is pleased to announce that its application to become a licensed...
Canary is Dropping the RX, and Adopting a Sleek New Look to Prepare for Licensing Canary is delighted to officially unveil our company-wide...